BackAcelrx Pharmaceuticals Overview

Acelrx Pharmaceuticals Current Cash

Latest current cash for ACRX: $3.8M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.82M
29.05% YoYΔ $-1.56M vs prior year quarter

Peer average

Loading

Acelrx Pharmaceuticals Current Cash History

Loading

Acelrx Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Acelrx Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acelrx Pharmaceuticals (ACRX) FAQ

As of the most recent data (March 2026), ACRX shows a current cash of $3.8M. That compares with $5.4M in the prior-year period — down 29.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACRX's current cash is now $3.8M (was $5.4M) — a 29.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Acelrx Pharmaceuticals is outperforming or lagging.

Tracking ACRX's current cash over time shows whether Acelrx Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $3.8M That compares with $5.4M in the prior-year period — down 29.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Acelrx Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $3.8M) with ownership activity and broader fundamentals.

Acelrx Pharmaceuticals's current cash is $3.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.